SPI buy recommendation investors chronicle20 Sep 2024 14:56
Investors Chronicle this week rate SPI as a buy. Earnings are expected to jump, rising demand for private healthcare, medium term targets reiterated, cost savings plans are on track. The consensus is EPS will more than triple between 2023 and 2027.